407 related articles for article (PubMed ID: 29367044)
1. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose?
Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ
Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044
[TBL] [Abstract][Full Text] [Related]
2. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
[TBL] [Abstract][Full Text] [Related]
3. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
[TBL] [Abstract][Full Text] [Related]
4. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
[TBL] [Abstract][Full Text] [Related]
5. Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis.
Farrar JE; Droege ME; Philpott CD; Mueller EW; Ernst NE; Makley AT; Deichstetter KM; Droege CA
J Surg Res; 2021 Aug; 264():425-434. PubMed ID: 33848842
[TBL] [Abstract][Full Text] [Related]
6. The ATLANTIC study: Anti-Xa level assessment in trauma intensive care.
Rakhra S; Martin EL; Fitzgerald M; Udy A
Injury; 2020 Jan; 51(1):10-14. PubMed ID: 31679829
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
[TBL] [Abstract][Full Text] [Related]
8. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
Bigos R; Solomon E; Dorfman JD; Ha M
J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
[TBL] [Abstract][Full Text] [Related]
9. Weight-Based Enoxaparin Achieves Adequate Anti-Xa Levels More Often in Trauma Patients: A Prospective Study.
Stutsrim AE; Eady JM; Collum M; Rebo GJ; Rebo KA; Miller PR; Nunn AM
Am Surg; 2021 Jan; 87(1):77-82. PubMed ID: 32915054
[TBL] [Abstract][Full Text] [Related]
10. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
Pannucci CJ; Prazak AM; Scheefer M
Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
[TBL] [Abstract][Full Text] [Related]
11. Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients.
Gates RS; Lollar DI; Collier BR; Smith J; Faulks ER; Gillen JR
J Trauma Acute Care Surg; 2022 Jan; 92(1):93-97. PubMed ID: 34561398
[TBL] [Abstract][Full Text] [Related]
12. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
[TBL] [Abstract][Full Text] [Related]
13. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
14. Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism.
Jones DL; Jones WA; Fleming KI; Higgins TF; Rothberg DL; Zhang Y; Pannucci CJ
J Orthop Trauma; 2019 Nov; 33(11):570-576. PubMed ID: 31634287
[TBL] [Abstract][Full Text] [Related]
15. Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting.
Rodier SG; Bukur M; Moore S; Frangos SG; Tandon M; DiMaggio CJ; Ayoung-Chee P; Marshall GT
Eur J Trauma Emerg Surg; 2021 Feb; 47(1):145-151. PubMed ID: 31471669
[TBL] [Abstract][Full Text] [Related]
16. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
Yam L; Bahjri K; Geslani V; Cotton A; Hong L
Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
[TBL] [Abstract][Full Text] [Related]
17. Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial.
Droege ME; Droege CA; Philpott CD; Webb ML; Ernst NE; Athota K; Wakefield D; Dowd JR; Gomaa D; Robinson BHR; Hanseman D; Elterman J; Mueller EW
J Thromb Thrombolysis; 2021 Nov; 52(4):1117-1128. PubMed ID: 33978907
[TBL] [Abstract][Full Text] [Related]
18. Relation of antifactor-Xa peak levels and venous thromboembolism after trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Martin AG; Lineen EB; Namias N; Schulman CI; Proctor KG
J Trauma Acute Care Surg; 2017 Dec; 83(6):1102-1107. PubMed ID: 29190255
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics Associated With Higher Enoxaparin Dosing Requirements for Venous Thromboembolism Prophylaxis in Trauma Patients.
Hashim YM; Dhillon NK; Veatch JM; Barmparas G; Ley EJ
Am Surg; 2021 Jul; 87(7):1177-1181. PubMed ID: 33342267
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
